Literature DB >> 14583607

The structure of the AXH domain of spinocerebellar ataxin-1.

Yu Wai Chen1, Mark D Allen, Dmitry B Veprintsev, Jan Löwe, Mark Bycroft.   

Abstract

Spinocerebellar ataxia type 1 is a late-onset neurodegenerative disease caused by the expansion of a CAG triplet repeat in the SCA1 gene. This results in the lengthening of a polyglutamine tract in the gene product ataxin-1. This produces a toxic gain of function that results in specific neuronal death. A region in ataxin-1, the AXH domain, exhibits significant sequence similarity to the transcription factor HBP1. This region of the protein has been implicated in RNA binding and self-association. We have determined the crystal structure of the AXH domain of ataxin-1. The AXH domain is dimeric and contains an OB-fold, a structural motif found in many oligonucleotide-binding proteins, supporting its proposed role in RNA binding. By structure comparison with other proteins that contain an OB-fold, a putative RNA-binding site has been identified. We also identified a cluster of charged surface residues that are well conserved among AXH domains. These residues may constitute a second ligand-binding surface, suggesting that all AXH domains interact with a common yet unidentified partner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14583607     DOI: 10.1074/jbc.M309817200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Nuclear ataxias.

Authors:  Harry T Orr
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05       Impact factor: 10.005

2.  Evolution and conservation of JmjC domain proteins in the green lineage.

Authors:  Yong Huang; Donghong Chen; Chunlin Liu; Wenhui Shen; Ying Ruan
Journal:  Mol Genet Genomics       Date:  2015-07-08       Impact factor: 3.291

Review 3.  Polyglutamine neurodegeneration: expanded glutamines enhance native functions.

Authors:  Harry T Orr
Journal:  Curr Opin Genet Dev       Date:  2012-01-25       Impact factor: 5.578

4.  Destabilizing the AXH Tetramer by Mutations: Mechanisms and Potential Antiaggregation Strategies.

Authors:  Gianvito Grasso; Umberto Morbiducci; Diana Massai; Jack A Tuszynski; Andrea Danani; Marco A Deriu
Journal:  Biophys J       Date:  2018-01-23       Impact factor: 4.033

Review 5.  Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.

Authors:  Huda Y Zoghbi; Harry T Orr
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

Review 6.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

Review 7.  The unstable repeats--three evolving faces of neurological disease.

Authors:  David L Nelson; Harry T Orr; Stephen T Warren
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

8.  Characterization of the zebrafish atxn1/axh gene family.

Authors:  Kerri M Carlson; Laura Melcher; Shaojuan Lai; Huda Y Zoghbi; H Brent Clark; Harry T Orr
Journal:  J Neurogenet       Date:  2008-12-10       Impact factor: 1.250

Review 9.  Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1.

Authors:  Antoni Matilla-Dueñas; Robert Goold; Paola Giunti
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

10.  Phosphorylation of S776 and 14-3-3 binding modulate ataxin-1 interaction with splicing factors.

Authors:  Cesira de Chiara; Rajesh P Menon; Molly Strom; Toby J Gibson; Annalisa Pastore
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.